- Report
- June 2022
- 257 Pages
Global
From €4995EUR$5,250USD£4,255GBP
- Report
- May 2022
- 170 Pages
Middle East
From €4995EUR$5,250USD£4,255GBP
- Report
- June 2022
- 124 Pages
Global
From €5233EUR$5,500USD£4,457GBP
- Report
- April 2021
- 209 Pages
Global
From €4710EUR$4,950USD£4,012GBP
- Report
- October 2022
- 118 Pages
Global
From €4662EUR$4,900USD£3,971GBP
- Report
- April 2023
- 120 Pages
Global
From €4519EUR$4,750USD£3,850GBP
- Report
- April 2023
- 110 Pages
Global
From €4519EUR$4,750USD£3,850GBP
- Report
- January 2022
- 120 Pages
Global
From €4519EUR$4,750USD£3,850GBP
- Report
- March 2021
- 146 Pages
Global
From €7607EUR$7,995USD£6,479GBP
- Report
- March 2020
- 141 Pages
Global
From €7607EUR$7,995USD£6,479GBP
- Report
- November 2018
- 258 Pages
Global
From €7607EUR$7,995USD£6,479GBP
- Report
- June 2021
Global
From €7607EUR$7,995USD£6,479GBP
- Report
- June 2019
- 130 Pages
United States
€2850EUR$2,995USD£2,427GBP
- Report
- October 2021
- 137 Pages
Global
From €4614EUR$4,850USD£3,931GBP
- Book
- October 2020
- 288 Pages
- Book
- October 2019
- 632 Pages
- Book
- April 2018
- 776 Pages
United States
Melanoma is a type of cancer that affects the skin and is the most serious form of skin cancer. It is caused by the uncontrolled growth of pigment-producing cells, known as melanocytes. Melanoma is the fifth most common cancer in the United States, with an estimated 87,110 new cases in 2020. It is also the leading cause of death from skin disease.
The melanoma market within the oncology space is a rapidly growing segment, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be driven by the increasing adoption of targeted therapies, immunotherapies, and combination therapies. Additionally, the increasing focus on personalized medicine and the development of novel drug delivery systems are expected to drive the market.
Some of the key players in the melanoma market include Bristol-Myers Squibb, Merck & Co., Novartis, Roche, Pfizer, and Eli Lilly. Show Less Read more